Related Experiment Videos
Oral vaccination against pseudotuberculosis
1Institute of Zoology, Zoological Society of London, UK.
Vaccine
|July 1, 1996
Summary
Oral administration of Yersinia pseudotuberculosis strain M5 protects mice against virulent strains. This low-virulence oral vaccine candidate offers protection against homologous and heterologous Yersinia strains.
Area of Science:
- Veterinary Microbiology
- Immunology
Background:
- Yersinia pseudotuberculosis causes disease in various animal species.
- Understanding virulence and protective immunity is crucial for disease control.
Purpose of the Study:
- To evaluate the immunoprotective potential of Yersinia pseudotuberculosis strain M5 against virulent homologous and heterologous strains.
- To assess the efficacy of oral administration of strain M5 as a vaccine candidate.
Main Methods:
- Mice were orally inoculated with Yersinia pseudotuberculosis strain M5.
- Vaccinated mice were subsequently challenged with virulent Yersinia pseudotuberculosis strains.
- Virulence, infection establishment, and lesion development were monitored.
Main Results:
- Oral administration of strain M5 conferred significant protection against lethal oral challenge with virulent Yersinia pseudotuberculosis.
- Strain M5 demonstrated protection against both homologous (serogroup IA) and heterologous (serogroup IA and IB) strains.
- While lesions developed in vaccinated mice upon challenge, they frequently became sterile, indicating immune control.
Conclusions:
- Yersinia pseudotuberculosis strain M5 is a promising candidate for oral immunization against yersiniosis.
- The findings suggest potential applications for vaccinating feral and captive wild animals to prevent pseudotuberculosis.